Secukinumab May Prevent Immune Cells From Producing Molecule Linked To Neurodegeneration In Parkinson’s Disease Patients, Study Suggests.
July 25, 2018
Parkinson’s News Today (7/24, Lopes) reports researchers found that Th17 immune cells “may be a key a promoter of neurodegeneration in Parkinson’s disease by producing the pro-inflammatory molecule interleukin-17 (IL-17),” and that Cosentyx (secukinumab)...